Avantor, Inc. (AVTR)
16.14
+0.05
(+0.31%)
USD |
NYSE |
Oct 16, 15:35
Avantor SG&A Expense (TTM) : 1.599B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.599B |
| March 31, 2026 | 1.609B |
| December 31, 2025 | 1.596B |
| September 30, 2025 | 1.574B |
| June 30, 2025 | 1.624B |
| March 31, 2025 | 1.604B |
| December 31, 2024 | 1.641B |
| September 30, 2024 | 1.657B |
| June 30, 2024 | 1.585B |
| March 31, 2024 | 1.537B |
| December 31, 2023 | 1.507B |
| September 30, 2023 | 1.482B |
| June 30, 2023 | 1.489B |
| March 31, 2023 | 1.483B |
| December 31, 2022 | 1.473B |
| September 30, 2022 | 1.543B |
| June 30, 2022 | 1.547B |
| March 31, 2022 | 1.567B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.530B |
| September 30, 2021 | 1.474B |
| June 30, 2021 | 1.424B |
| March 31, 2021 | 1.377B |
| December 31, 2020 | 1.374B |
| September 30, 2020 | 1.325B |
| June 30, 2020 | 1.327B |
| March 31, 2020 | 1.375B |
| December 31, 2019 | 1.369B |
| September 30, 2019 | 1.374B |
| June 30, 2019 | 1.390B |
| March 31, 2019 | 1.391B |
| December 31, 2018 | 1.406B |
| September 30, 2018 | 1.53B |
| June 30, 2018 | 1.184B |
| March 31, 2018 | 809.90M |
| December 31, 2017 | 457.20M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Medpace Holdings, Inc. | 189.02M |
| Champions Oncology, Inc. | 21.81M |
| Personalis, Inc. | 67.03M |
| Adaptive Biotechnologies Corp. | 180.38M |
| 10X Genomics, Inc. | 297.01M |